Comparative in-vitro anti-inflammatory, anticholinesterase and antidiabetic evaluation: computational and kinetic assessment of succinimides cyano-acetate derivatives.

doi:10.1080/07391102.2022.2069862

Paper

Comparative in-vitro anti-inflammatory, anticholinesterase and antidiabetic evaluation: computational and kinetic assessment of succinimides cyano-acetate derivatives.

Published May 4, 2022 · A. Pervaiz, M. Jan, S. M. Hassan Shah

Journal of biomolecular structure & dynamics

Q2 SJR score

10

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

This research was planned to synthesize cyano-acetate derivatives of succinimide and evaluate its comparative biological efficacy as anti-inflammatory, anti-cholinesterase and anti-diabetic, which was further validated by molecular docking studies. The three cyano-acetate derivatives of succinimide including compound 23 Methyl 2-cyano-2-(2,5-dioxopyrrolidin-3-yl)acetate, compound 31 Methyl 2-cyano-2-(1-methyl-2,5-dioxopyrrolidin-3-yl)acetate and compound 44 Methyl 2-cyano-2-(1-ethyl-2,5-dioxopyrrolidin-3-yl) acetate were synthesized. The mentioned compounds were checked for in vitro anti-inflammatory, anti-cholinesterase and anti-diabetic (α-amylase inhibition) activity. To validate the in vitro results, computational studies were carried out using molecular operating environment to analyse the BE, i.e. binding energies of all synthesized compounds against the respective enzymes. The Compounds 23, 31, 44 exhibited anti-inflammatory via inhibiting COX-2 (IC50 value of 204.08, 68.60 and 50.93 µM, respectively), COX-1 (IC50 value of 287, 185, and 143 µM, respectively) and 5-LOX (IC50 value of 138, 50.76 and 20, 87 µM respectively). They exhibited choline-mimetic potential, such as compound 23, 31 and 44 inhibited AChE enzyme (IC50 value of 240, 174, and 134 µM, respectively) and BChE enzyme (IC50 value of 203, 134 and 97 µM, respectively). The Compounds 23, 31, 44 exhibited anti-diabetic effect via inhibiting α-amylase enzyme (IC50 values of 250, 106 and 60 µM, respectively). Molecular docking studies revealed that the synthesized compounds have good binding affinity in the binding pockets of AChE, BChE, COX-2, 5-LOX and α-amylase enzyme and showed high binding energies. The synthesized succinimide derivatives, i.e. compound 23, 31, 44 showed marked inhibitory activities against cyclooxygenase, lipoxygenase, α-amylase and cholinesterase enzymes. Among these three, compound 44 and 31 showed strong anti-inflammatory and anti-diabetic activity while they displayed moderate anti-cholinesterase activity supported by molecular docking results.Communicated by Ramaswamy H. Sarma.

In Vitro Study

Study Snapshot

Cyano-acetate derivatives of succinimide show strong anti-inflammatory and anti-diabetic activity, with compound 44 and 31 showing strong anti-cholinesterase activity.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Comparative in-vitro anti-inflammatory, anticholinesterase and antidiabetic evaluation: computational and kinetic assessment of succinimides cyano-acetate derivatives.

Sign up to use Study Snapshot

References

Tailoring phenol photomineralization pathway over polymeric carbon nitride with cyano group multifunctional active sites

Modifying polymeric carbon nitride with cyano group sites improves phenol photomineralization performance by enhancing adsorption, activation, and surface charge states.

Mechanistic evaluation of a novel cyclohexanone derivative's functionality against nociception and inflammation: an in-vitro, in-vivo and in-silico approach.

CHD shows potential anti-nociceptive and anti-inflammatory properties, likely mediated through GABAergic and opioidergic interactions, COX-2 and 5-LOX enzyme inhibition, and reduced pro-inflammatory cytokine expression.

Phytochemical profiling of bioactive compounds, anti-inflammatory and analgesic potentials of Habenaria digitata Lindl.: Molecular docking based synergistic effect of the identified compounds.

Habenaria digitata contains bioactive compounds that synergistically manage inflammation and analgesia, with chloroform and ethyl acetate fractions being particularly rich in these compounds.

Treating Hyperglycemia From Eryngium caeruleum M. Bieb: In-vitro α-Glucosidase, Antioxidant, in-vivo Antidiabetic and Molecular Docking-Based Approaches

Eryngium caeruleum has potential antidiabetic and antioxidant properties, with the most active sample showing a concentration-dependent inhibition of -glucosidase and significant scavenging effect against free radicals.

Pcal_0842, a highly thermostable glycosidase from Pyrobaculum calidifontis displays both α-1,4- and β-1,4-glycosidic cleavage activities.

Pcal_0842 is a highly thermostable glycosidase from Pyrobaculum calidifontis, displaying both -1,4- and -1,4-glycosidic cleavage activities at temperatures up to 120°C.

Synthesis, in-vitro, in-vivo anti-inflammatory activities and molecular docking studies of acyl and salicylic acid hydrazide derivatives.

The synthesized compounds show promising anti-inflammatory properties, with 4-amiontirazole showing the most potent COX-2 inhibitory activity.

Editorial: Natural Products-Based Drugs: Potential Therapeutics Against Alzheimer’s Disease and Other Neurological Disorders

Natural products-based drugs show potential as effective and safe alternatives to existing Alzheimer's disease treatments, with potential for clinical trials in mild to moderate dementia.

Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents.

N-substituted pyrrolidine-2,5-dione derivatives show potential as multitarget anti-inflammatory agents with COX-2 selectivity and show safety up to 1000 mg/kg dose in in-vivo studies.

Citations

Design, Synthesis, Molecular Docking, and Anti‐Inflammatory Potential of Amide Coupling Carboxylate Derivatives

New amide-based carboxylate derivatives show significant anti-inflammatory potentials, with some showing close binding energies to standard drugs montelukast and diclofenac.

Phenolic phytochemistry, in vitro, in silico, in vivo, and mechanistic anti-inflammatory and antioxidant evaluations of Habenaria digitata

Habenaria digitata contains active compounds with potential anti-inflammatory and antioxidant effects, supporting their ethnomedicinal use for inflammation and oxidative stress.

Exploration of Succinimide Derivative as a Multi-Target, Anti-Diabetic Agent: In Vitro and In Vivo Approaches

Compound 3 shows potential as a multi-targeted, anti-diabetic agent by inhibiting multiple targets and exhibiting good antioxidant potential.

Exploration of ketone derivatives of succinimide for their antidiabetic potential: In vitro and in vivo approaches

Ketone-containing succinimides show excellent potential against diabetes, with compounds 1 and 4 showing excellent inhibition of -glucosidase and -amylase enzymes in vitro and in vivo studies.

Phytochemical Profiling, Anti-Inflammatory, Anti-Oxidant and In-Silico Approach of Cornus macrophylla Bioss (Bark)

The ethyl acetate fraction of Cornus macrophylla shows promising anti-inflammatory and antioxidant properties, with potential for future drug development against inflammation.